<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $9,207 on July 28, 2017. Performance is located in North Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of August 27, 2017. No set-aside category applies.</p>
<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences Of California, Inc. on July 7, 2017, for $4,525.00 under firm fixed-price terms. Work is to be performed in North Bethesda, Maryland, with an ultimate completion date of August 6, 2017. The purchase order covers sequencing consumables or reagents supporting the institute's genomic research operations.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $5,712.00 on August 18, 2017, with ultimate completion by September 15, 2017. Place of performance is Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. Specific deliverables or line items are not detailed in the source.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $11,980.00 on August 24, 2017, with completion by September 22, 2017. Performance occurs in Bethesda, Maryland. The order procures laboratory supplies and equipment on a firm fixed-price basis with no set-aside designation.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Neogen Corp for $16,800.00 on April 9, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. Ultimate completion date is April 9, 2018. No additional detail regarding the specific items or services procured appears in the source.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $3,639.24 on September 26, 2017, with completion by October 18, 2017. Performance occurs in Bethesda, Maryland. The order provides laboratory instrumentation, reagents, or consumables; specific line items are not detailed in the award record. Pricing is firm fixed price with no set-aside applied.</p>